Lisa K. Miller
Known title: See RemarksCIK: 0002036749
Associated companies
Transaction History
| LFST | ▼ Sell | Open Market | 47,912 | $520K | 8/10/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 14,766 | $102K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 26,836 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 13,446 | $93K | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 21,590 | $150K | 3/6/2026 | View on chart |
| LFST | ▲ Buy | Grant | 107,914 | $0 | 3/5/2026 | View on chart |
| LFST | ▼ Sell | Open Market | 57,240 | $368K | 11/21/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 10,623 | $68K | 11/10/2025 | View on chart |
| LFST | ▼ Sell | Open Market | 18,845 | $130K | 3/17/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 10,655 | $76K | 3/10/2025 | View on chart |
| LFST | ▲ Buy | Grant | 76,142 | $0 | 3/6/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 6,431 | $51K | 3/6/2025 | View on chart |
| LFST | ▼ Sell | Open Market | 10,540 | $79K | 11/13/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.